Postrero, Francisca D.

HRN: 04-43-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/08/2025
06/14/2025
IV
500mg
OD
CAP MR
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines